Cargando…

Differences in Advanced Magnetic Resonance Imaging in MOG-IgG and AQP4-IgG Seropositive Neuromyelitis Optica Spectrum Disorders: A Comparative Study

Aims: To explore differences in advanced brain magnetic resonance imaging (MRI) characteristics between myelin oligodendrocyte (MOG) immunoglobulin (IgG) and aquaporin-4 (AQP4) IgG seropositive (+) neuromyelitis optica spectrum disorders (NMOSD). Methods: 33 AQP4-IgG and 18 MOG-IgG seropositive NMOS...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmidt, Felix A., Chien, Claudia, Kuchling, Joseph, Bellmann-Strobl, Judith, Ruprecht, Klemens, Siebert, Nadja, Asseyer, Susanna, Jarius, Sven, Brandt, Alexander U., Scheel, Michael, Paul, Friedemann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7554609/
https://www.ncbi.nlm.nih.gov/pubmed/33101166
http://dx.doi.org/10.3389/fneur.2020.499910
_version_ 1783593814970073088
author Schmidt, Felix A.
Chien, Claudia
Kuchling, Joseph
Bellmann-Strobl, Judith
Ruprecht, Klemens
Siebert, Nadja
Asseyer, Susanna
Jarius, Sven
Brandt, Alexander U.
Scheel, Michael
Paul, Friedemann
author_facet Schmidt, Felix A.
Chien, Claudia
Kuchling, Joseph
Bellmann-Strobl, Judith
Ruprecht, Klemens
Siebert, Nadja
Asseyer, Susanna
Jarius, Sven
Brandt, Alexander U.
Scheel, Michael
Paul, Friedemann
author_sort Schmidt, Felix A.
collection PubMed
description Aims: To explore differences in advanced brain magnetic resonance imaging (MRI) characteristics between myelin oligodendrocyte (MOG) immunoglobulin (IgG) and aquaporin-4 (AQP4) IgG seropositive (+) neuromyelitis optica spectrum disorders (NMOSD). Methods: 33 AQP4-IgG and 18 MOG-IgG seropositive NMOSD patients and 61 healthy control (HC) subjects were included. All 112 participants were scanned with the same standardized MRI-protocol on a 3-Tesla MRI-scanner. Brain volume and diffusion tensor imaging (DTI) parameters were assessed. Results: MOG-IgG+ patients showed reduced parallel diffusivity within white matter tracts compared to HC whereas AQP4-IgG+ showed no significant brain parenchymal damage in DTI analysis. AQP4-IgG+ patients showed reduced whole brain volumes and reduced volumes of several deep gray matter structures compared to HC whereas MOG-IgG+ patients did not show reduced brain or deep gray matter volumes compared to HC. Conclusions: Microstructural brain parenchymal damage in MOG-IgG+ patients was more pronounced than in AQP4-IgG+ patients, compared with HC, whereas normalized brain volume reduction was more severe in AQP4-IgG+ patients. Longitudinal imaging studies are warranted to further investigate this trend in NMOSD. Our results suggest that MOG-IgG+ and AQP4-IgG+ NMOSD patients differ in cerebral MRI characteristics. Advanced MRI analysis did not help to differentiate between MOG-IgG+ and AQP4-IgG+ patients in our study.
format Online
Article
Text
id pubmed-7554609
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-75546092020-10-22 Differences in Advanced Magnetic Resonance Imaging in MOG-IgG and AQP4-IgG Seropositive Neuromyelitis Optica Spectrum Disorders: A Comparative Study Schmidt, Felix A. Chien, Claudia Kuchling, Joseph Bellmann-Strobl, Judith Ruprecht, Klemens Siebert, Nadja Asseyer, Susanna Jarius, Sven Brandt, Alexander U. Scheel, Michael Paul, Friedemann Front Neurol Neurology Aims: To explore differences in advanced brain magnetic resonance imaging (MRI) characteristics between myelin oligodendrocyte (MOG) immunoglobulin (IgG) and aquaporin-4 (AQP4) IgG seropositive (+) neuromyelitis optica spectrum disorders (NMOSD). Methods: 33 AQP4-IgG and 18 MOG-IgG seropositive NMOSD patients and 61 healthy control (HC) subjects were included. All 112 participants were scanned with the same standardized MRI-protocol on a 3-Tesla MRI-scanner. Brain volume and diffusion tensor imaging (DTI) parameters were assessed. Results: MOG-IgG+ patients showed reduced parallel diffusivity within white matter tracts compared to HC whereas AQP4-IgG+ showed no significant brain parenchymal damage in DTI analysis. AQP4-IgG+ patients showed reduced whole brain volumes and reduced volumes of several deep gray matter structures compared to HC whereas MOG-IgG+ patients did not show reduced brain or deep gray matter volumes compared to HC. Conclusions: Microstructural brain parenchymal damage in MOG-IgG+ patients was more pronounced than in AQP4-IgG+ patients, compared with HC, whereas normalized brain volume reduction was more severe in AQP4-IgG+ patients. Longitudinal imaging studies are warranted to further investigate this trend in NMOSD. Our results suggest that MOG-IgG+ and AQP4-IgG+ NMOSD patients differ in cerebral MRI characteristics. Advanced MRI analysis did not help to differentiate between MOG-IgG+ and AQP4-IgG+ patients in our study. Frontiers Media S.A. 2020-09-30 /pmc/articles/PMC7554609/ /pubmed/33101166 http://dx.doi.org/10.3389/fneur.2020.499910 Text en Copyright © 2020 Schmidt, Chien, Kuchling, Bellmann-Strobl, Ruprecht, Siebert, Asseyer, Jarius, Brandt, Scheel and Paul. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Schmidt, Felix A.
Chien, Claudia
Kuchling, Joseph
Bellmann-Strobl, Judith
Ruprecht, Klemens
Siebert, Nadja
Asseyer, Susanna
Jarius, Sven
Brandt, Alexander U.
Scheel, Michael
Paul, Friedemann
Differences in Advanced Magnetic Resonance Imaging in MOG-IgG and AQP4-IgG Seropositive Neuromyelitis Optica Spectrum Disorders: A Comparative Study
title Differences in Advanced Magnetic Resonance Imaging in MOG-IgG and AQP4-IgG Seropositive Neuromyelitis Optica Spectrum Disorders: A Comparative Study
title_full Differences in Advanced Magnetic Resonance Imaging in MOG-IgG and AQP4-IgG Seropositive Neuromyelitis Optica Spectrum Disorders: A Comparative Study
title_fullStr Differences in Advanced Magnetic Resonance Imaging in MOG-IgG and AQP4-IgG Seropositive Neuromyelitis Optica Spectrum Disorders: A Comparative Study
title_full_unstemmed Differences in Advanced Magnetic Resonance Imaging in MOG-IgG and AQP4-IgG Seropositive Neuromyelitis Optica Spectrum Disorders: A Comparative Study
title_short Differences in Advanced Magnetic Resonance Imaging in MOG-IgG and AQP4-IgG Seropositive Neuromyelitis Optica Spectrum Disorders: A Comparative Study
title_sort differences in advanced magnetic resonance imaging in mog-igg and aqp4-igg seropositive neuromyelitis optica spectrum disorders: a comparative study
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7554609/
https://www.ncbi.nlm.nih.gov/pubmed/33101166
http://dx.doi.org/10.3389/fneur.2020.499910
work_keys_str_mv AT schmidtfelixa differencesinadvancedmagneticresonanceimaginginmogiggandaqp4iggseropositiveneuromyelitisopticaspectrumdisordersacomparativestudy
AT chienclaudia differencesinadvancedmagneticresonanceimaginginmogiggandaqp4iggseropositiveneuromyelitisopticaspectrumdisordersacomparativestudy
AT kuchlingjoseph differencesinadvancedmagneticresonanceimaginginmogiggandaqp4iggseropositiveneuromyelitisopticaspectrumdisordersacomparativestudy
AT bellmannstrobljudith differencesinadvancedmagneticresonanceimaginginmogiggandaqp4iggseropositiveneuromyelitisopticaspectrumdisordersacomparativestudy
AT ruprechtklemens differencesinadvancedmagneticresonanceimaginginmogiggandaqp4iggseropositiveneuromyelitisopticaspectrumdisordersacomparativestudy
AT siebertnadja differencesinadvancedmagneticresonanceimaginginmogiggandaqp4iggseropositiveneuromyelitisopticaspectrumdisordersacomparativestudy
AT asseyersusanna differencesinadvancedmagneticresonanceimaginginmogiggandaqp4iggseropositiveneuromyelitisopticaspectrumdisordersacomparativestudy
AT jariussven differencesinadvancedmagneticresonanceimaginginmogiggandaqp4iggseropositiveneuromyelitisopticaspectrumdisordersacomparativestudy
AT brandtalexanderu differencesinadvancedmagneticresonanceimaginginmogiggandaqp4iggseropositiveneuromyelitisopticaspectrumdisordersacomparativestudy
AT scheelmichael differencesinadvancedmagneticresonanceimaginginmogiggandaqp4iggseropositiveneuromyelitisopticaspectrumdisordersacomparativestudy
AT paulfriedemann differencesinadvancedmagneticresonanceimaginginmogiggandaqp4iggseropositiveneuromyelitisopticaspectrumdisordersacomparativestudy